<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000635682">
  <TermName>AC-T</TermName>
  <TermDefinition>
    <DefinitionText>An abbreviation for a chemotherapy combination used to treat breast cancer. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide, followed by treatment with paclitaxel (Taxol). Also called AC-T regimen and AC-Taxol regimen.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <SpanishTermName>AC-T</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Nombre de una quimioterapia combinada que se usa para el tratamiento del cáncer de mama.   Incluye los medicamentos clorhidrato de doxorrubicina (Adriamycin) y ciclofosfamida, seguidos de tratamiento con paclitaxel (Taxol).   También se llama régimen AC-T y régimen AC-Taxol.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2009-02-20</DateFirstPublished>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000630806" url="/about-cancer/treatment/drugs/AC-T">AC-T</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
